Stay updated on Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new site revision label Revision: v3.5.4 was added, and the previous label Revision: v3.5.3 was removed. This reflects a minor platform update rather than a change to study content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s displayed software/theme revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the site's version history.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check111 days agoChange DetectedRevision: v3.4.2 is now displayed and the previous government funding lapse notice (v3.4.1) has been removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Radiotherapy in Soft Tissue Sarcoma Clinical Trial page.